Biocon Biologics UK Ltd
Quick facts
Marketed products
- Stelara · Immunology
Stelara binds to the p40 subunit of IL-12 and IL-23, reducing inflammation in autoimmune diseases.
Phase 3 pipeline
- Bmab 1000
Bmab 1000 is a monoclonal antibody targeting a specific molecular pathway, though the exact target is not publicly disclosed in available sources. - Bmab1200
Bmab1200 is a monoclonal antibody targeting a specific immune or disease-related antigen to modulate immune response or block pathogenic signaling.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: